You found MEDVi through an ad promising GLP-1 medications starting at $179 per month. The price is real, but it applies only to the first month. Ongoing costs run $299 to $399 depending on the medication. That gap between the advertised price and the actual monthly cost is the central tension in every MEDVi review.
MEDVi is a legitimate telehealth platform. It is LegitScript certified, partners with licensed compounding pharmacies, and holds a 4.0-star Trustpilot rating across 9,400+ reviews. It also carries a BBB F rating and documented transparency concerns. Both facts matter.
| Detail | Information |
|---|---|
| Company | MEDVi (medvi.org) |
| Founded | 2023 |
| Type | Telehealth weight loss platform |
| Medications | Compounded semaglutide, compounded tirzepatide, brand Ozempic |
| First Month | $179 (semaglutide injection) to $349 (tirzepatide injection) |
| Ongoing Monthly | $299 (semaglutide injection) to $399 (tirzepatide) |
| Trustpilot | 4.0 stars, 9,400+ reviews |
| BBB Rating | F |
| LegitScript | Certified |
| Insurance | Not accepted (HSA/FSA eligible) |
| Pharmacy Partners | Belmar Pharma Solutions, Link Compound Pharmacy |
| Guarantee | 5-month results guarantee (conditions apply) |
Get your custom peptide protocol:
- Tailored to your body and goals
- Precise dosing and cycle length
- Safe stacking combinations
- Backed by peer-reviewed studies
- Ready in under 2 minutes
What Is MEDVi?
MEDVi is a telehealth technology platform that connects patients with licensed providers who prescribe GLP-1 weight loss medications. The company launched in 2023 and operates nationwide through a fully online model. No in-person visits. No physical clinics.
A critical distinction: MEDVi is not itself a medical practice. Their terms of service state that MEDVi "does not provide any Healthcare Services through the Platform and is not licensed to practice medicine." The company operates a three-entity model:
- MEDVi handles the website, billing, and patient onboarding
- OpenLoop Health / CareGLP Affiliated P.C.s provide the licensed physicians
- Belmar Pharma Solutions (FDA-registered 503B facility, established 1985) compounds and ships the medications
This structure explains why some patients report being bounced between entities when billing or medical issues arise. It is also standard among telehealth weight loss platforms.
The medications are compounded versions of semaglutide and tirzepatide. MEDVi also offers brand-name Ozempic at roughly $1,999 per month. Most patients choose the compounded options. The company is registered in Newark, Delaware (131 Continental Dr, Ste 305) and holds LegitScript certification.
How MEDVi Works
The process follows four steps.
- 1.You complete a health questionnaire covering medical history, current medications, allergies, and weight loss goals. The form takes about 10 minutes.
- 2.A licensed provider reviews your submission within 24 hours. They determine whether GLP-1 treatment is appropriate for your situation. If lab work is needed, MEDVi arranges testing through Quest Diagnostics at no additional cost.
- 3.Your medication ships in temperature-controlled packaging directly to your door. Most patients receive their first shipment within 3 to 5 days of approval.
- 4.Ongoing monitoring includes 24/7 provider messaging, dose adjustments based on your progress, and follow-up consultations every 3 to 6 months.
The speed is MEDVi's strongest selling point. Most competitors take one to two weeks from signup to medication delivery. MEDVi consistently delivers within a week, and same-day consultations are sometimes available.
MEDVi Pricing Breakdown
Every MEDVi plan includes the provider consultation, medication, shipping, and access to 24/7 messaging. Lab work is covered when medically necessary. There are no separate membership fees.
Pricing by Medication
| Medication | Format | First Month | Ongoing Monthly |
|---|---|---|---|
| Compounded semaglutide | Weekly injection | $179 | $299 |
| Compounded semaglutide | Daily oral tablet | $249 | $349-$369 |
| Compounded tirzepatide | Weekly injection | $279-$349 | $399 |
| Compounded tirzepatide | Daily oral tablet | $279 | $399 |
| Brand-name Ozempic | Weekly injection | ~$1,999 | ~$1,999 |
Sources: MEDVi website, Vaccine Alliance, NutritionNC. Prices verified March 2026.
Compounded semaglutide injections are the lowest-cost option at $299 per month after the introductory period. Tirzepatide options (both injectable and oral) settle at $399 per month regardless of format. The brand-name Ozempic path costs roughly six times the compounded alternative.
For context on how these medications differ and how to calculate your specific dose, see our semaglutide dosage calculator and tirzepatide dosage calculator.
Hidden Costs to Watch
The 67% price increase from month one ($179) to month two ($299) for semaglutide injections is the most common surprise reported by new patients. MEDVi's advertising emphasizes the first-month price. The ongoing rate appears in the FAQ section and during checkout but not in the initial ad.
Three billing details to know before signing up:
- MEDVi bills every 28 days, not monthly. That means 13 billing cycles per year, not 12.
- Cancellation has no self-service button. You must contact support directly.
- The 5-month money-back guarantee has strict conditions. Any weight fluctuation, even 1 pound of gain, may disqualify you from a refund.
None of these are hidden in a legal sense. They are disclosed in the terms. But they are not prominently communicated before checkout.
Medications Available Through MEDVi
MEDVi prescribes compounded versions of the two dominant GLP-1 weight loss drugs: semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). Both are available as weekly injections and daily oral tablets.
What Compounded Means
Compounded medications are prepared by licensed pharmacies according to a doctor's prescription. They use the same active ingredients as brand-name drugs but are not FDA-approved products. They may differ from brand-name versions in formulation, concentration, and inactive ingredients.
This is standard practice across the telehealth weight loss industry. Hims, Ro, Henry Meds, and most online GLP-1 providers prescribe compounded versions. The cost savings are significant: compounded semaglutide runs $299 per month versus $1,000+ for brand-name Wegovy.
MEDVi's pharmacy partners include Belmar Pharma Solutions (operating since 1985) and Link Compound Pharmacy. Both are licensed facilities. For more on compounded formulations, see our semaglutide B12 compound guide.
Injectable vs. Oral: What MEDVi Offers
MEDVi is one of the few telehealth platforms offering both injectable and oral formats for both semaglutide and tirzepatide. Most competitors offer injections only.
The injectable format is a weekly subcutaneous injection, the same administration method used in the clinical trials that established GLP-1 efficacy. If you are new to self-injection, our injection guide walks through the process step by step.
The oral tablet format is a daily dose. Oral GLP-1 medications generally produce somewhat less weight loss than injectable versions in clinical data (16.6% vs. 20%+ body weight reduction). The convenience tradeoff matters to patients who refuse injections.
Trust and Transparency Analysis
MEDVi's trust profile is genuinely split. Strong signals coexist with real concerns.
What Checks Out
Trustpilot: 4.0 stars across 9,400+ reviews. The review volume is substantial and the rating is above average for telehealth weight loss platforms. Most positive reviews cite fast shipping, responsive support, and effective weight loss on the medication.
LegitScript: Certified. LegitScript verifies that telehealth companies comply with healthcare regulations, including proper licensing and pharmacy standards. MEDVi holds current certification.
Pharmacy partners are licensed. Belmar Pharma Solutions has operated since 1985. Link Compound Pharmacy is a licensed 503A facility. The active ingredients in the medications are the same compounds used in the major weight loss clinical trials.
Providers are licensed. MEDVi's physicians operate through OpenLoop Health, a regulated telehealth staffing network. Prescriptions are written by board-certified providers.
What Raises Questions
BBB: F rating with 311 complaints. The Better Business Bureau assigned MEDVi its lowest grade. The BBB profile shows 311 filed complaints and a 1.23 out of 5 average customer review score across 191 reviews. The company is not BBB-accredited and failed to respond to at least 5 complaints. An F rating does not mean fraud. It means the BBB has logged a volume of unresolved complaints about billing, refunds, and service delivery.
Transparency score: 35/100. An independent review by NutritionNC, which tested the platform firsthand, scored MEDVi 35 out of 100 on transparent operations. The reviewer could not verify media endorsement claims (logos from the New York Times, Healthline, and Fortune displayed on the website). The cited articles could not be located through those publications.
Pharmacy disclosure resistance. The same review reported difficulty obtaining pharmacy partner information by phone. The company disclosed Link Compound Pharmacy only after persistent email follow-up.
Checkout pressure tactics. Countdown timers and urgency messaging appear during the checkout process. These are marketing techniques, not clinical tools.
What Real Users Say
We reviewed feedback across Trustpilot, ConsumerAffairs, Reddit, and independent review sites. The patterns are consistent.
Positive Feedback Patterns
- Fast approval and shipping (most patients start treatment within one week)
- Responsive 24/7 chat support (rated the best communication channel)
- Effective weight loss results on the medication itself
- Simple fully-online process with no in-person visits required
- Providers willing to adjust dosages based on side effects and progress
- Both injectable and oral options give patients a choice
The medication works. Compounded semaglutide and tirzepatide contain the same active ingredients that produced 15 to 22% body weight loss in clinical trials. Patient results on MEDVi's platform are consistent with those findings. The platform's clinical fundamentals are sound.
Common Complaints
- First-month promotional pricing creates sticker shock at renewal
- No self-service cancellation: you must call or message support to cancel
- Guarantee conditions changed from 3 months to 5 months, with strict weight-loss thresholds
- Some reports of medication shipments delayed or never arriving after payment
- Billing every 28 days continues regardless of shipment timing
- Packaging quality concerns: vials reported loose or improperly packed in some shipments
- Refund disputes documented on BBB and Reddit
The complaints cluster around billing practices and expectations management, not around the medication or medical care itself. This is a common pattern across telehealth weight loss platforms that use auto-billing subscription models.
One additional risk factor: the FDA sent warning letters to 50+ GLP-1 compounders in September 2025 and has announced intent to further restrict compounded GLP-1 access. MEDVi has not received a specific warning letter, but its entire business model depends on the legal ability to compound semaglutide and tirzepatide. This regulatory landscape is evolving. See our FDA peptide crackdown analysis for context.
For information on managing common GLP-1 side effects, see our guides on semaglutide nausea and tirzepatide dosage adjustment.
MEDVi vs. Alternatives
| Platform | Monthly Cost | Insurance | Medications | Standout Feature |
|---|---|---|---|---|
| MEDVi | $299-$399 | No | Compounded sema + tirze (injection + oral) | 24/7 provider messaging |
| Hims | $199-$499 | No | Compounded semaglutide | Brand recognition, oral options |
| Ro | $145+/mo | Some plans | Compounded sema + tirze | Weekly coaching included |
| Found | $39+/mo | Yes | Multiple med options | Behavioral coaching, insurance |
| Henry Meds | $249/mo | No | Compounded sema + tirze | Lower flat rate |
| Shed | $199-$699 | No | Compound + brand options | Widest medication selection |
MEDVi sits in the middle of the market on pricing. It costs more than Ro and Found but less than Shed's premium tiers. Its 24/7 provider messaging is a real differentiator; most competitors limit messaging to business hours.
The critical difference is medication variety. MEDVi offers compounded semaglutide and tirzepatide in both injectable and oral formats. Competitors like Shed and Mochi Health carry brand-name options (Wegovy, Mounjaro, Zepbound) that MEDVi does not. If your insurance covers brand-name GLP-1 drugs, Found or Ro will likely save you more over time.
For a broader look at all peptide sourcing options, see our 2026 buyer's guide.
Who Should Use MEDVi
MEDVi is a good fit if you:
- Want compounded GLP-1 medications without insurance hassles
- Prefer a fully online process with no in-person visits
- Value 24/7 provider access for dosage questions and side effect management
- Want both injectable and oral medication options
- Are comfortable paying $299 to $399 per month out of pocket
MEDVi is not ideal if you:
- Need insurance to cover your GLP-1 medication (try Found or Ro instead)
- Prefer brand-name drugs like Wegovy, Mounjaro, or Zepbound
- Want structured behavioral coaching alongside medication
- Are uncomfortable with compounded (non-FDA-approved) formulations
- Prioritize transparent business practices above all else in a healthcare provider
The platform serves a specific patient: someone who wants fast, convenient access to compounded GLP-1 medications, is paying cash, and does not need hand-holding through the weight loss process. If that describes you, MEDVi delivers. If you need more structure, coaching, or insurance coverage, other platforms fit better.
Frequently Asked Questions
Is MEDVi legit?
MEDVi is a legitimate telehealth company. It holds LegitScript certification, partners with licensed compounding pharmacies (Belmar Pharma Solutions, Link Compound Pharmacy), and employs board-certified providers through OpenLoop Health. It has 9,400+ Trustpilot reviews with a 4.0-star average. However, it also carries a BBB F rating driven by billing complaints.
How much does MEDVi cost per month?
After the first-month introductory price ($179 for semaglutide injections), ongoing costs are $299/month for compounded semaglutide injections, $349-$369 for semaglutide tablets, and $399/month for any tirzepatide option. MEDVi bills every 28 days, which means 13 billing cycles per year instead of 12.
Does MEDVi accept insurance?
No. MEDVi operates on a cash-pay model and does not bill insurance directly. You can use HSA or FSA cards, though coverage is not guaranteed. If your insurance covers brand-name GLP-1 drugs, platforms like Found or Ro may be more cost-effective.
What medications does MEDVi prescribe?
MEDVi prescribes compounded semaglutide (injectable and oral), compounded tirzepatide (injectable and oral), and brand-name Ozempic (~$1,999/month). The compounded versions use the same active ingredients as Wegovy, Ozempic, Mounjaro, and Zepbound but are prepared by licensed compounding pharmacies, not the original manufacturers.
How fast can I start treatment with MEDVi?
Most patients complete the health questionnaire, receive provider approval within 24 hours, and get medication delivered within 3 to 5 days. Total time from signup to first dose is typically under one week. Same-day consultations are sometimes available. This is faster than most competitors.
Can I cancel MEDVi anytime?
MEDVi states there is no long-term commitment. However, there is no self-service cancel button in the patient portal. Cancellation requires contacting customer support directly. You must cancel within your current 28-day billing cycle to avoid being charged for the next cycle.
Is compounded semaglutide from MEDVi safe?
Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy. It is prepared by licensed pharmacies (Belmar Pharma Solutions, Link Compound Pharmacy) but is not an FDA-approved product. This is standard across telehealth GLP-1 providers. The medication is prescribed by licensed physicians after a medical review.
How does MEDVi compare to Hims or Ro?
MEDVi costs $299-$399/month, similar to Hims ($199-$499). Ro starts lower at $145+/month and accepts some insurance. MEDVi's advantage is 24/7 provider messaging and both injectable and oral options. Ro includes weekly coaching. Hims has stronger brand recognition. All three prescribe compounded GLP-1 medications.
The Bottom Line
MEDVi delivers what it advertises: fast access to compounded GLP-1 medications through a licensed telehealth platform with 24/7 provider support. The clinical fundamentals are solid. The pricing, once past the first-month discount, runs $299 to $399 per month. The trust profile is mixed: strong Trustpilot presence alongside a BBB F rating and transparency gaps that independent reviewers have documented.
If you choose MEDVi, read the billing terms before you pay. Know that the first-month price is promotional. Know that cancellation requires contacting support. And know that the medication itself, compounded semaglutide or tirzepatide, contains the same active ingredients used in the clinical trials that produced 15 to 22% body weight reduction.
For help calculating your specific dose, use our free semaglutide dosage calculator or tirzepatide dosage calculator. For a complete overview of semaglutide dosing or tirzepatide dosing, see our dosage guides. If you are weighing all your options, start with our peptide safety guide.
Not Sure Which Peptide Protocol Is Right for You?
Take our 2-minute quiz for a personalized recommendation based on your goals and health profile.
Start the Quiz →